Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1992-10-2
|
| pubmed:abstractText |
The results obtained with [131I]metaiodobenzylguanidine (131I-MIBG) treatment in 6 patients affected by metastatic carcinoid are reported. 131I-MIBG was given in single doses of 3.7-8.0 GBq, reaching a maximum cumulative dose of 29.5 GBq in 4 courses. Objective responses were not observed, but in 4 cases an apparent stabilisation of the disease for more than 1 year was obtained. A subjective response regarding the carcinoid syndrome was observed in 4 cases. No response was seen in 2 cases. No adverse side-effects of any importance were observed, usually being prevented by a mild medication.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0368-3249
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
35
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
343-5
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:1823854-3-Iodobenzylguanidine,
pubmed-meshheading:1823854-Adult,
pubmed-meshheading:1823854-Antineoplastic Agents,
pubmed-meshheading:1823854-Carcinoid Tumor,
pubmed-meshheading:1823854-Combined Modality Therapy,
pubmed-meshheading:1823854-Female,
pubmed-meshheading:1823854-Humans,
pubmed-meshheading:1823854-Iodine Radioisotopes,
pubmed-meshheading:1823854-Iodobenzenes,
pubmed-meshheading:1823854-Liver Neoplasms,
pubmed-meshheading:1823854-Male,
pubmed-meshheading:1823854-Middle Aged
|
| pubmed:articleTitle |
Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid.
|
| pubmed:affiliation |
Nuclear Medicine Service, Spedali Civili, Brescia, Italy.
|
| pubmed:publicationType |
Journal Article
|